VitaProtech

VitaProtech delivers advanced security solutions, integrating state-of-the-art technology to safeguard assets in various sectors. The company focuses on enhancing security frameworks through innovative and comprehensive offerings in the security landscape. VitaProtech, founded in 1987, is headquartered in Vaulx-en-Velin, France, and specializes in providing high-level security solutions. The company underwent a significant strategic shift when it was acquired by Seven2 in July 2022 from Eurazeo PME, thereby transitioning to new management while retaining its core operational focus.

The exact details of previous business pivots are not documented, and there is no mention of subsidiaries or parent companies. The founder’s specific background is not publicly detailed, but VitaProtech has made a total of 3 deals, with its latest funding round being a Secondary Buyout raising EUR 40. 00 mn, which matches the total amount raised to date. VitaProtech specializes in comprehensive security solutions that integrate access control, video surveillance, and intrusion detection into a unified platform.

These solutions are primarily delivered through its flagship product, designed for both public and private sectors, addressing complex security challenges in industries such as government, healthcare, education, and critical infrastructure. The company's technology is trusted by a diverse client base, including over 12,000 customers globally, with strong penetration in North America and Europe. In the most recent fiscal year of 2021, VitaProtech reported a revenue of EUR 2,682,015. 90, with an EBITDA of EUR -50,028.

80. The company operates on a B2B transaction model, generating revenue through integrated security systems, software subscriptions, hardware sales, and maintenance contracts, exemplified by its multi-year agreements for the Velocity One product. VitaProtech aims to capitalize on its recent funding, focusing on expanding its product portfolio and exploring entry into new geographic markets. The company is reportedly designing innovative security products set to launch within the next year.

Additionally, VitaProtech plans to penetrate new markets in Europe and Asia by 2024, leveraging the EUR 40. 00 mn raised in its latest funding round to bolster these initiatives. The acquisition by Seven2 is expected to enhance operational capabilities, aligning with their growth strategy.